Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Products > Assay Kits > ADA Assay Kits

ADA Assay Kits

Assess immunogenicity with validated ADA assay kits — bridging ELISA format for anti-drug antibody screening, confirmation, and titration. Compatible with major biologic drug classes. RUO

Why Researchers Choose abinScience

Ready-to-Use Convenience Pre-coated plates, optimized buffers, and step-by-step protocols — reliable results in 3–5 hours.
High Sensitivity Detection limits as low as 1–15 pg/mL depending on the analyte, with excellent linearity.
Reproducible & Reliable CV <10% intra-assay, <15% inter-assay. Every kit lot is QC-tested before release.
Matched Antibody Pairs Capture and detection antibodies optimized together for maximum signal-to-noise ratio.
Complete Kit Contents Standards, detection reagents, substrate, stop solution, and plate sealers included — no hidden extras.

Documents & QC Data

Download kit manuals, standard curves, CoA, and troubleshooting guides on each product page. All documents are lot-specific and available as PDF.

FAQs

What sample types are compatible?

Most kits work with serum, plasma, cell culture supernatant, and tissue lysate. Specific validated sample types are listed in each kit manual.

How sensitive are your ELISA kits?

Typical sensitivity ranges from 1–15 pg/mL depending on the analyte. Each kit datasheet specifies the exact minimum detectable dose (MDD).

How long does the assay take?

Standard sandwich ELISA protocols complete in 3–5 hours. Some kits offer rapid formats finishing in under 90 minutes.

Do kits include standards and controls?

Yes — all kits include lyophilized standards, detection reagents, substrate, and stop solution. Positive controls are included in select kits.

Can I use your kits for multiplex detection?

Our standard kits are singleplex. For multiplex needs, individual kit components can often be adapted. Contact us for guidance on panel design.

"

Options+
Options
Confirm
  • Product types
    0 selected
    Assay Kit (337)
  • Target
    0 selected
    Tosatoxumab (1)
    Glycoprotein (4)
    Navicixizumab (1)
    Sotrovimab (1)
    Rituximab (1)
    Lodelcizumab (1)
    Palivizumab (3)
    Ianalumab (1)
    NP/Nucleocapsid (3)
    Varisacumab (1)
    Belantamab (1)
    Ziltivekimab (1)
    Tigatuzumab (1)
    Lenzilumab (1)
    Pembrolizumab (3)
    Semorinemab (1)
    Ipilimumab (2)
    Utomilumab (1)
    Cixutumumab (1)
    Pogalizumab (1)
    Trastuzumab (2)
    Ixekizumab (1)
    Obinutuzumab (2)
    Anifrolumab (1)
    Daclizumab (1)
    Emibetuzumab (1)
    Etanercept (1)
    Tiragolumab (2)
    Semaglutide (1)
    Casirivimab (1)
    H3L (2)
    Retatrutide (1)
    Suptavumab (1)
    Elotuzumab (1)
    Ontamalimab (1)
    Varlilumab (1)
    Tanezumab (1)
    Teclistamab (1)
    Carlumab (1)
    Indatuximab (1)
    Ascrinvacumab (1)
    Namilumab (1)
    Sintilimab (1)
    Tilavonemab (1)
    Tremelimumab (1)
    Daratumumab (3)
    Infliximab (2)
    Dalotuzumab (1)
    Andecaliximab (1)
    Vofatamab (1)
    Depatuxizumab (1)
    Tavolimab (1)
    Zanidatamab (1)
    Afutuzumab (1)
    Cusatuzumab (1)
    Blosozumab (1)
    Obiltoxaximab (1)
    GP/Envelope glycoprotein (3)
    Atezolizumab (3)
    Imdevimab (1)
    Tezepelumab (1)
    E8L (4)
    β-D-Glucan (1)
    Evolocumab (1)
    Vorsetuzumab (1)
    Ibalizumab (1)
    Tocilizumab (3)
    Crizanlizumab (1)
    Cergutuzumab (1)
    Otilimab (1)
    Tislelizumab (1)
    Zagotenemab (1)
    Zalifrelimab (1)
    Magrolimab (1)
    Figitumumab (1)
    Losatuxizumab (1)
    Lirilumab (1)
    Icrucumab (1)
    Romosozumab (1)
    Romiplostim (1)
    Enoblituzumab (1)
    Tirzepatide (1)
    Avelumab (3)
    A35R (4)
    Remtolumab (1)
    Suvizumab (1)
    Alirocumab (1)
    Tregalizumab (1)
    Glembatumumab (1)
    Inclacumab (1)
    Talacotuzumab (1)
    Adalimumab (3)
    Pasotuxizumab (1)
    Labetuzumab (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    Faricimab (1)
    Cinpanemab (1)
    Toripalimab (1)
    Ifabotuzumab (1)
    Canakinumab (1)
    Ganitumab (1)
    Farletuzumab (1)
    Oxelumab (1)
    Necitumumab (1)
    Zenocutuzumab (1)
    Epcoritamab (1)
    Eculizumab (3)
    Mirzotamab (1)
    Gremubamab (1)
    Durvalumab (3)
    Denosumab (3)
    Elezanumab (1)
    RBD (4)
    Siltuximab (3)
    Secukinumab (2)
    Glofitamab (1)
    Ieramilimab (1)
    Benufutamab (1)
    Meplazumab (1)
    Zanolimumab (1)
    Lacnotuzumab (1)
    Vibecotamab (1)
    Rosopatamab (2)
    Nesvacumab (1)
    Milatuzumab (1)
    Befovacimab (1)
    Edrecolomab (1)
    Gevokizumab (1)
    Sibrotuzumab (1)
    Teprotumumab (1)
    Mirvetuximab (1)
    Panitumumab (3)
    Codrituzumab (1)
    Foravirumab (1)
    Ustekinumab (3)
    Mirikizumab (2)
    Sarilumab (2)
    Omburtamab (1)
    Glycoprotein G (2)
    Pacmilimab (1)
    Cetuximab (3)
    RBD (Delta) (2)
    Clazakizumab (1)
    Ibritumomab (1)
    Conatumumab (1)
    Balstilimab (1)
    Olaratumab (1)
    Certolizumab (2)
    Tarextumab (1)
    Cabiralizumab (1)
    Tisotumab (1)
    Oleclumab (1)
    Vanucizumab (1)
    CD79B (2)
    Concizumab (1)
    Letolizumab (1)
    Bevacizumab (3)
    Dupilumab (3)
    Serclutamab (1)
    Tibulizumab (1)
    Rafivirumab (1)
    RBD (Omicron/BA.5) (3)
    Natalizumab (2)
    A29L (4)
    F/Fusion glycoprotein F0 (3)
    Enfortumab (1)
    Spike glycoprotein (10)
    CD20/MS4A1 (3)
    Astegolimab (1)
    Olokizumab (1)
    Mosunetuzumab (1)
    Mavezelimab (1)
    Drozitumab (1)
    Alacizumab (1)
    Eldelumab (1)
    Cetrelimab (1)
    Sacituzumab (1)
    Tovetumab (1)
    Emactuzumab (1)
    Disitamab (1)
    Afasevikumab (1)
    Marstacimab (1)
    Rolinsatamab (1)
    Basiliximab (1)
    Amatuximab (1)
    Apamistamab (1)
    Brolucizumab (1)
    Vunakizumab (1)
    dsDNA (1)
    Dilpacimab (1)
    Omalizumab (2)
    Frovocimab (1)
    M1R (4)
    Exenatide acetate (2)
    Nirsevimab (1)
    Guselkumab (3)
    Spike Protein (Trimer) (2)
    Mazdutide (1)
    Iscalimab (1)
    Tesidolumab (1)
    Sirukumab (1)
    Ocaratuzumab (1)
    Favezelimab (1)
    Lexatumumab (1)
    Ramucirumab (1)
    Nivolumab (3)
    Bimagrumab (1)
    Golimumab (3)
    Urelumab (1)
    Imalumab (1)
    Zampilimab (1)
    Lupartumab (1)
    Ivuxolimab (1)
    Pertuzumab (3)
    Bimekizumab (1)
    Itolizumab (1)
    Camidanlumab (1)
    Anetumab (1)
    Ranibizumab (3)
  • Applications
    0 selected
    ELISA (337)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only